Deer­field taps NYU Lan­gone Health as lat­est aca­d­e­m­ic part­ner, ink­ing $130M trans­la­tion­al re­search pact

Deer­field Man­age­ment is ready to add an­oth­er aca­d­e­m­ic re­search cen­ter to its net­work of part­ners, with a com­mit­ment of up to $130 mil­lion over the next 10 years.

NYU Lan­gone Health will work with Deer­field via a new com­pa­ny called Amethyst In­no­va­tions, which will sup­port re­search projects at the med­ical cen­ters in hopes of speed­ing up the ul­ti­mate com­mer­cial­iza­tion of those dis­cov­er­ies.

It joins Co­lum­bia, Har­vard, Duke, Dana-Far­ber and a few oth­ers in sim­i­lar trans­la­tion­al re­search arrange­ments with Deer­field. The New York City-based in­vest­ment firm says such part­ner­ships of­fer an al­ter­na­tive path for re­searchers to take their work for­ward, in­clud­ing both sci­en­tif­ic and op­er­a­tional sup­port as drug can­di­dates ma­te­ri­al­ize and move to­ward the clin­ic. In turn, Deer­field hopes to keep a close re­la­tion­ship with the sci­en­tists be­hind cut­ting-edge in­sights and tech­nolo­gies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.